We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Oxygen-Deprived RNA Molecules Found to Lead to Tumor Progression

By LabMedica International staff writers
Posted on 09 Nov 2014
Print article
New research has discovered a previously unknown phenomenon: key regulatory molecules are decreased when deprived of oxygen, which leads to increased cancer progression in vitro and in vivo.

As tumors grow, they can outgrow their blood supply, leaving some of the tumor with areas where the tissue is oxygen starved, a condition known as tumor hypoxia. Conventional wisdom would suggest the lack of oxygen would inhibit growth. However, new insights into hypoxia has been gleaned in a study by investigators from the University of Texas MD Anderson Cancer Center (Houston, TX, USA), which examined at how specific enzymes were impacted. Unexpectedly, hypoxia led to tumor progression. Meaning, cancer cells are clever and able to modify to maintain sustained growth.

“We showed that that hypoxia causes a downregulation of, or decrease in, quantities of Drosha and Dicer, enzymes that are necessary for producing microRNAs (miRNAs). MiRNAs are molecules naturally expressed by the cell that regulate a variety of genes,” said Anil Sood, MD, professor of gynecologic oncology and reproductive medicine and cancer biology. “At a functional level, this process results in increased cancer progression when studied at the cellular level.”

Dr. Sood’s findings were published October 2014 in the journal Nature Communications. Dr. Sood also was part of a study led by the Ontario Cancer Institute (Toronto, Canada), which reported in the same issue on hypoxia and regulation of DICER in breast cancer.

The investigators discovered that hypoxia-altered miRNA’s ability to mature in cells. Given that about one-third of the body’s genes are controlled by miRNA, Dr. Sood noted that it was not surprising that cancer cells have modified miRNA levels and that miRNAs are extensively involved in cancer progression. “Although global miRNA downregulation in cancer has been reported, the mechanism behind it has not been fully understood,” he said. “We already knew that downregulation of the enzymes Drosha and Dicer in ovarian, lung, and breast cancer is associated with poor patient outcomes. In this study, we identified new methods for downregulation of miRNA.”

This chain of events delayed development of miRNA in its tracks, due to hypoxia leading to reduced levels of Drosha and Dicer. Rajesha Rupaimoole, a graduate student in the cancer biology program and first author of the study demonstrated that the disruption of molecular machinery depends on the transcription factors, ETS1 and ELK1 in order to successfully decrease one of the enzymes, Drosha, which accordingly fuels continued tumor growth. Transcription factors are proteins that switch genetic instructions on and off.

Dr. Sood’s team, however, demonstrated that ETS1 and ELK1 could be “silenced” when deprived of oxygen in vivo when they were targeted by specific RNA molecules known as small interfering RNA (siRNA). “The rescue of Drosha by siRNAs targeting ETS1 and ELK1 led to significant tumor regression,” said Mr. Rupaimoole.

With a better determination how hypoxia regulates critical enzymes, Dr. Sood believes that there is potential for a new approach to halting tumor progression. “Use of Drosha- and Dicer-independent siRNA-based gene targeting is an emerging strategy to develop therapies that target undruggable genes,” said Mr. Rupaimoole. “A comprehensive understanding of Drosha and Dicer downregulation under hypoxic conditions is an important leap towards comprehending how miRNA can go awry during cancer progression.”

Related Links:

University of Texas MD Anderson Cancer Center


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Unit-Dose Packaging solution
HLX
New
Sulfidoleukotrienes (sLT) Assay
CAST ELISA
New
Serum Toxicology Benzodiazepine Assay
DRI Serum Toxicology Benzodiazepine Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Schematic overview of maternal biomarker discovery using cell-free RNA during pregnancy (Photo courtesy of Circulation Research (2024). DOI: 10.1161/CIRCRESAHA.124.325024)

Maternal Blood Test Identifies Congenital Heart Diseases in Fetus

Each year, around 1,000 children are born with a single ventricle heart defect (SVHD), a condition where one of the heart's lower chambers is underdeveloped, too small, or missing a valve.... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.